Regeneron Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2020
Total Assets: $17.16B
Liabilities Breakdown FY2020
Total Liabilities: $6.14B
Asset Breakdown
Total Assets: $17.16B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.19B | 12.8% |
| Accounts Receivable | $4.11B | 24.0% |
| Inventory | $1.92B | 11.2% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.94B | 52.1% |
Liabilities Breakdown
Total Liabilities: $6.14B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $475.5M | 7.7% |
| Long-Term Debt | $1.98B | 32.2% |
| Other Liabilities | $3.68B | 60.0% |